Secretory diarrhoea is characterized by a change in the gut from an absorptive state to a secretory state, often caused by toxins or secretagogues. Chronic diarrhoea is usually caused by an underlying condition and can be classified into three subtypes: secretory, osmotic, and inflammatory. Secretory diarrhoea is characterized by large daily stool volumes and can occur even during fasting or sleep due to disrupted ion channels in the gastrointestinal tract. Osmotic diarrhoea is caused by something in the gut forcing water back into the lumen, often seen in malabsorption. Inflammatory diarrhoea is caused by inflammation of the bowel wall, either from medical disease or invasive organisms. Acute infectious diarrhoea can be invasive or enterotoxic/non-invasive, with the former presenting with bloody stool, leukocytosis, and fever, and the latter presenting with a watery stool and lacking systemic symptoms. In either case, WBCs can be detected in the stool.

Understanding Diarrhoea: Causes and Characteristics

Diarrhoea is defined as having more than three loose or watery stools per day. It can be classified as acute if it lasts for less than 14 days and chronic if it persists for more than 14 days. Gastroenteritis, diverticulitis, and antibiotic therapy are common causes of acute diarrhoea. On the other hand, irritable bowel syndrome, ulcerative colitis, Crohn’s disease, colorectal cancer, and coeliac disease are some of the conditions that can cause chronic diarrhoea.

Symptoms of gastroenteritis may include abdominal pain, nausea, and vomiting. Diverticulitis is characterized by left lower quadrant pain, diarrhoea, and fever. Antibiotic therapy, especially with broad-spectrum antibiotics, can also cause diarrhoea, including Clostridium difficile infection. Chronic diarrhoea may be caused by irritable bowel syndrome, which is characterized by abdominal pain, bloating, and changes in bowel habits. Ulcerative colitis may cause bloody diarrhoea, crampy abdominal pain, and weight loss. Crohn’s disease may cause crampy abdominal pain, diarrhoea, and malabsorption. Colorectal cancer may cause diarrhoea, rectal bleeding, anaemia, and weight loss. Coeliac disease may cause diarrhoea, abdominal distension, lethargy, and weight loss.

Other conditions associated with diarrhoea include thyrotoxicosis, laxative abuse, appendicitis, and radiation enteritis. It is important to seek medical attention if diarrhoea persists for more than a few days or is accompanied by other symptoms such as fever, severe abdominal pain, or blood in the stool.

Amylase is an enzyme that converts starch into sugars.

Enzymes play a crucial role in the breakdown of carbohydrates in the gastrointestinal system. Amylase, which is present in both saliva and pancreatic secretions, is responsible for breaking down starch into sugar. On the other hand, brush border enzymes such as maltase, sucrase, and lactase are involved in the breakdown of specific disaccharides. Maltase cleaves maltose into glucose and glucose, sucrase cleaves sucrose into fructose and glucose, while lactase cleaves lactose into glucose and galactose. These enzymes work together to ensure that carbohydrates are broken down into their simplest form for absorption into the bloodstream.

The distal lesser curvature of the stomach is supplied by the right gastric artery, while the proximal lesser curvature is supplied by the left gastric artery. The proximal greater curvature is supplied by the left gastroepiploic artery, and the distal greater curvature is supplied by the right gastroepiploic artery.

The Gastroduodenal Artery: Supply and Path

The gastroduodenal artery is responsible for supplying blood to the pylorus, proximal part of the duodenum, and indirectly to the pancreatic head through the anterior and posterior superior pancreaticoduodenal arteries. It commonly arises from the common hepatic artery of the coeliac trunk and terminates by bifurcating into the right gastroepiploic artery and the superior pancreaticoduodenal artery.

To better understand the relationship of the gastroduodenal artery to the first part of the duodenum, the stomach is reflected superiorly in an image sourced from Wikipedia. This artery plays a crucial role in providing oxygenated blood to the digestive system, ensuring proper functioning and health.

Barrett’s oesophagus is characterized by the replacement of the original stratified squamous epithelium with columnar epithelium, which is typically found lining the intestines. Simple cuboidal epithelium is present in small gland ducts, kidney tubules, and secretory portions. Pseudostratified columnar epithelium is found in the upper respiratory tract and trachea, while stratified squamous epithelium lines areas that experience tension, such as the mouth, oesophagus, and vagina.

Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, which increases the risk of oesophageal adenocarcinoma by 50-100 fold. It is usually identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia, as there are no screening programs for it. The length of the affected segment determines the chances of identifying metaplasia, with short (<3 cm) and long (>3 cm) subtypes. The prevalence of Barrett’s oesophagus is estimated to be around 1 in 20, and it is identified in up to 12% of those undergoing endoscopy for reflux.

The columnar epithelium in Barrett’s oesophagus may resemble that of the cardiac region of the stomach or that of the small intestine, with goblet cells and brush border. The single strongest risk factor for Barrett’s oesophagus is gastro-oesophageal reflux disease (GORD), followed by male gender, smoking, and central obesity. Alcohol is not an independent risk factor for Barrett’s, but it is associated with both GORD and oesophageal cancer. Patients with Barrett’s oesophagus often have coexistent GORD symptoms.

The management of Barrett’s oesophagus involves high-dose proton pump inhibitor, although the evidence base for its effectiveness in reducing the progression to dysplasia or inducing regression of the lesion is limited. Endoscopic surveillance with biopsies is recommended every 3-5 years for patients with metaplasia but not dysplasia. If dysplasia of any grade is identified, endoscopic intervention is offered, such as radiofrequency ablation, which is the preferred first-line treatment, particularly for low-grade dysplasia, or endoscopic mucosal resection.

Hepatic encephalopathy, which this patient is experiencing due to acute liver failure from paracetamol overdose, is caused by ammonia crossing the blood-brain barrier. The liver’s inability to convert ammonia to urea, which is normally excreted by the kidneys, leads to an increase in ammonia levels. Although ammonia typically has low permeability across the blood-brain barrier, high levels can cause cerebral edema and encephalopathy through active transport.

The King’s College Criteria for liver transplant in acute liver failure includes grade 3/4 encephalopathy, which this patient has, along with meeting criteria for INR and creatinine levels.

While hypoglycemia can cause encephalopathy, it is not the most likely cause in this case. Liver failure does not cause raised uric acid levels, and although high levels of urea can cause encephalopathy, this patient’s urea levels are low due to the liver’s inability to produce it from ammonia and CO2.

Although N-acetylcysteine can cause allergic reactions and angioedema, it is not associated with the development of encephalopathy.

Hepatic encephalopathy is a condition that can occur in any liver disease. Its exact cause is not fully understood, but it is believed to involve the absorption of excess ammonia and glutamine from the breakdown of proteins by gut bacteria. While it is commonly associated with acute liver failure, it can also be seen in chronic liver disease. In fact, many patients with liver cirrhosis may experience mild cognitive impairment before the more recognizable symptoms of hepatic encephalopathy appear. Transjugular intrahepatic portosystemic shunting (TIPSS) may also trigger encephalopathy.

The symptoms of hepatic encephalopathy can range from irritability to coma, with confusion, altered consciousness, and incoherence being common. Other features may include the inability to draw a 5-pointed star, arrhythmic negative myoclonus, and triphasic slow waves on an EEG. The condition can be graded from I to IV, with Grade IV being the most severe.

Several factors can precipitate hepatic encephalopathy, including infection, gastrointestinal bleeding, constipation, drugs, hypokalaemia, renal failure, and increased dietary protein. Treatment involves addressing any underlying causes and using medications such as lactulose and rifaximin. Lactulose promotes the excretion of ammonia and increases its metabolism by gut bacteria, while rifaximin modulates the gut flora, resulting in decreased ammonia production. Other options include embolisation of portosystemic shunts and liver transplantation in selected patients.

Co-danthramer is a genotoxic laxative that should only be prescribed to patients receiving palliative care due to its potential to cause cancer. Other laxatives should be considered first for patients with constipation. However, if constipation is not improved by other laxatives, co-danthramer may be prescribed to palliative patients. It is important to note that a high-fibre diet, adequate fluid intake, and exercise are recommended for all patients with constipation. Fruits and vegetables high in fibre and sorbitol, as well as fruit juices high in sorbitol, can also be helpful in preventing and treating constipation.

Understanding Laxatives

Laxatives are frequently prescribed medications in clinical practice, with constipation being a common issue among patients. While constipation may be a symptom of underlying pathology, many patients experience simple idiopathic constipation. The British National Formulary (BNF) categorizes laxatives into four groups: osmotic, stimulant, bulk-forming, and faecal softeners.

Osmotic laxatives, such as lactulose, macrogols, and rectal phosphates, work by drawing water into the bowel to soften stools and promote bowel movements. Stimulant laxatives, including senna, docusate, bisacodyl, and glycerol, stimulate the muscles in the bowel to contract and move stool along. Co-danthramer, a combination of a stimulant and a bulk-forming laxative, should only be prescribed to palliative patients due to its potential carcinogenic effects.

Bulk-forming laxatives, such as ispaghula husk and methylcellulose, work by increasing the bulk of stool and promoting regular bowel movements. Faecal softeners, such as arachis oil enemas, are not commonly prescribed but can be used to soften stool and ease bowel movements.

In summary, understanding the different types of laxatives and their mechanisms of action can help healthcare professionals prescribe the most appropriate treatment for patients experiencing constipation.

Ischaemic colitis commonly affects the splenic flexure, which is a watershed area for arterial supply from the superior and inferior mesenteric artery. The descending colon is supplied by the left colic branch of the inferior mesenteric artery, while the hepatic flexure is supplied by the right colic branch of the superior mesenteric artery. The rectum receives arterial blood from the inferior mesenteric artery, middle rectal artery (from internal iliac artery), and inferior rectal artery (from the internal pudendal artery). The sigmoid colon is the second most common site for ischaemic colitis and is also a watershed area known as ‘Sudeck’s point’.

Understanding Ischaemic Colitis

Ischaemic colitis is a condition that occurs when there is a temporary reduction in blood flow to the large bowel. This can cause inflammation, ulcers, and bleeding. The condition is more likely to occur in areas of the bowel that are located at the borders of the territory supplied by the superior and inferior mesenteric arteries, such as the splenic flexure.

When investigating ischaemic colitis, doctors may look for a sign called thumbprinting on an abdominal x-ray. This occurs due to mucosal edema and hemorrhage. It is important to diagnose and treat ischaemic colitis promptly to prevent complications and ensure a full recovery.

BWS can also cause gigantism, which may explain the macrosomia observed in this case. Genetic and chromosomal abnormalities are commonly associated with omphalocoele, and genetic studies are conducted to detect any such abnormalities early on, not just Down’s syndrome.

The US findings indicate the presence of an omphalocoele, not a gastroschisis, which is an abdominal wall defect without a membranous sac covering, usually located to the right of a normal umbilical cord insertion site. As such, genetic studies are not used to diagnose either defect, and this option is incorrect.

Omphalocoele can be diagnosed without genetic studies, but if the membranous sac ruptures in utero, there may be some uncertainty in the diagnosis. In such cases, genetic studies can help confirm the diagnosis, given the high incidence of associated genetic abnormalities with omphalocoele.

While foetuses with omphalocoele are more likely to have associated structural defects, genetic studies are not useful in identifying these. An echocardiogram would be a more effective means of detecting any other structural defects.

Gastroschisis and Exomphalos: Congenital Visceral Malformations

Gastroschisis and exomphalos are both types of congenital visceral malformations. Gastroschisis is a condition where there is a defect in the anterior abdominal wall, located just beside the umbilical cord. On the other hand, exomphalos, also known as omphalocoele, is a condition where the abdominal contents protrude through the anterior abdominal wall, but are covered by an amniotic sac formed by amniotic membrane and peritoneum.

In terms of management, vaginal delivery may be attempted for gastroschisis, and newborns should be taken to the operating room as soon as possible after delivery, ideally within four hours. For exomphalos, a caesarean section is indicated to reduce the risk of sac rupture. A staged repair may be undertaken as primary closure may be difficult due to lack of space or high intra-abdominal pressure. If this occurs, the sac is allowed to granulate and epithelialize over the coming weeks or months, forming a shell. As the infant grows, a point will be reached when the sac contents can fit within the abdominal cavity. At this point, the shell will be removed, and the abdomen closed.

Overall, both gastroschisis and exomphalos require careful management and monitoring to ensure the best possible outcomes for the newborn.

What forms the front wall of the inguinal canal? The external oblique aponeurosis forms the front wall. To access the canal and perform a hernia repair, the aponeurosis is divided. The posterior wall is made up of the transversalis fascia and conjoint tendons, which are not typically cut to gain entry to the inguinal canal.

The External Oblique Muscle: Anatomy and Function

The external oblique muscle is one of the three muscles that make up the anterolateral aspect of the abdominal wall. It is the outermost muscle and plays an important role in supporting the abdominal viscera. The muscle originates from the outer surfaces of the lowest eight ribs and inserts into the anterior two-thirds of the outer lip of the iliac crest. The remaining portion of the muscle becomes the aponeurosis, which fuses with the linea alba in the midline.

The external oblique muscle is innervated by the ventral rami of the lower six thoracic nerves. Its main function is to contain the abdominal viscera and raise intra-abdominal pressure. Additionally, it can move the trunk to one side. The aponeurosis of the external oblique muscle also forms the anterior wall of the inguinal canal, which is an important anatomical landmark in the groin region.

Overall, the external oblique muscle is a crucial component of the abdominal wall and plays an important role in maintaining the integrity of the abdominal cavity. Its unique anatomy and function make it an important muscle for both movement and protection of the internal organs.

The patient’s familial background indicates the possibility of Lynch syndrome, given that several of his close relatives developed cancer at a young age. This is supported by the fact that his family has a history of both colorectal cancer, which may indicate a defect in the APC gene, and endometrial cancer, which is also linked to Lynch syndrome. Lynch syndrome is associated with mutations in mismatch repair genes such as MSH2, MLH1, PMS2, and GTBP, which are responsible for identifying and repairing errors that occur during DNA replication, such as insertions and deletions of bases. Mutations in these genes can increase the risk of developing cancers such as colorectal, endometrial, and renal cancer.

Colorectal cancer can be classified into three types: sporadic, hereditary non-polyposis colorectal carcinoma (HNPCC), and familial adenomatous polyposis (FAP). Sporadic colon cancer is believed to be caused by a series of genetic mutations, including allelic loss of the APC gene, activation of the K-ras oncogene, and deletion of p53 and DCC tumor suppressor genes. HNPCC, which is an autosomal dominant condition, is the most common form of inherited colon cancer. It is caused by mutations in genes involved in DNA mismatch repair, leading to microsatellite instability. The most common genes affected are MSH2 and MLH1. Patients with HNPCC are also at a higher risk of other cancers, such as endometrial cancer. The Amsterdam criteria are sometimes used to aid diagnosis of HNPCC. FAP is a rare autosomal dominant condition that leads to the formation of hundreds of polyps by the age of 30-40 years. It is caused by a mutation in the APC gene. Patients with FAP are also at risk of duodenal tumors. A variant of FAP called Gardner’s syndrome can also feature osteomas of the skull and mandible, retinal pigmentation, thyroid carcinoma, and epidermoid cysts on the skin. Genetic testing can be done to diagnose HNPCC and FAP, and patients with FAP generally have a total colectomy with ileo-anal pouch formation in their twenties.

The most common type of colorectal cancer is adenocarcinoma, which originates from the mucosal lining of the colon. Initially, it develops as a benign adenoma from glandular cells of the mucosa, which later transforms into a malignant form.

Squamous cell carcinoma arises from squamous cells, which are not present in the colon. Ductal carcinoma is a breast cancer that originates from ductal cells. Basal cell carcinoma is a type of skin cancer, while mesothelioma is a malignancy that affects the mesothelium, commonly found in the lining of the chest wall.

Colorectal cancer is a prevalent type of cancer in the UK, ranking third in terms of frequency and second in terms of cancer-related deaths. Every year, approximately 150,000 new cases are diagnosed, and 50,000 people die from the disease. The cancer can occur in different parts of the colon, with the rectum being the most common location, accounting for 40% of cases. The sigmoid colon follows closely, with 30% of cases, while the descending colon has only 5%. The transverse colon has 10% of cases, and the ascending colon and caecum have 15%.

The right colon and terminal ileum are supplied by the ileocolic artery, which is a branch of the SMA. Meanwhile, the middle colic artery supplies the transverse colon. During cancer resections, it is common practice to perform high ligation as veins and lymphatics also run alongside the arteries in the mesentery. The ileocolic artery originates from the SMA close to the duodenum.

The colon begins with the caecum, which is the most dilated segment of the colon and is marked by the convergence of taenia coli. The ascending colon follows, which is retroperitoneal on its posterior aspect. The transverse colon comes after passing the hepatic flexure and becomes wholly intraperitoneal again. The splenic flexure marks the point where the transverse colon makes an oblique inferior turn to the left upper quadrant. The descending colon becomes wholly intraperitoneal at the level of L4 and becomes the sigmoid colon. The sigmoid colon is wholly intraperitoneal, but there are usually attachments laterally between the sigmoid and the lateral pelvic sidewall. At its distal end, the sigmoid becomes the upper rectum, which passes through the peritoneum and becomes extraperitoneal.

The arterial supply of the colon comes from the superior mesenteric artery and inferior mesenteric artery, which are linked by the marginal artery. The ascending colon is supplied by the ileocolic and right colic arteries, while the transverse colon is supplied by the middle colic artery. The descending and sigmoid colon are supplied by the inferior mesenteric artery. The venous drainage comes from regional veins that accompany arteries to the superior and inferior mesenteric vein. The lymphatic drainage initially follows nodal chains that accompany supplying arteries, then para-aortic nodes.

The colon has both intraperitoneal and extraperitoneal segments. The right and left colon are part intraperitoneal and part extraperitoneal, while the sigmoid and transverse colon are generally wholly intraperitoneal. The colon has various relations with other organs, such as the right ureter and gonadal vessels for the caecum/right colon, the gallbladder for the hepatic flexure, the spleen and tail of pancreas for the splenic flexure, the left ureter for the distal sigmoid/upper rectum, and the ureters, autonomic nerves, seminal vesicles, prostate, and urethra for the rectum.

Microsatellite instability of DNA repair genes causes Lynch syndrome, which is identified by the presence of aggressive colon cancer on the right side and endometrial cancer.

Colorectal cancer can be classified into three types: sporadic, hereditary non-polyposis colorectal carcinoma (HNPCC), and familial adenomatous polyposis (FAP). Sporadic colon cancer is believed to be caused by a series of genetic mutations, including allelic loss of the APC gene, activation of the K-ras oncogene, and deletion of p53 and DCC tumor suppressor genes. HNPCC, which is an autosomal dominant condition, is the most common form of inherited colon cancer. It is caused by mutations in genes involved in DNA mismatch repair, leading to microsatellite instability. The most common genes affected are MSH2 and MLH1. Patients with HNPCC are also at a higher risk of other cancers, such as endometrial cancer. The Amsterdam criteria are sometimes used to aid diagnosis of HNPCC. FAP is a rare autosomal dominant condition that leads to the formation of hundreds of polyps by the age of 30-40 years. It is caused by a mutation in the APC gene. Patients with FAP are also at risk of duodenal tumors. A variant of FAP called Gardner’s syndrome can also feature osteomas of the skull and mandible, retinal pigmentation, thyroid carcinoma, and epidermoid cysts on the skin. Genetic testing can be done to diagnose HNPCC and FAP, and patients with FAP generally have a total colectomy with ileo-anal pouch formation in their twenties.

The likely diagnosis for this patient is a Clostridium difficile infection, which is a gram-positive bacillus bacteria. This infection is triggered by recent broad-spectrum antibiotic use, as seen in this patient who was prescribed ceftriaxone for meningitis. The patient’s symptoms of crampy abdominal pain and sudden onset diffuse diarrhoea, along with a marked rise in white blood cells, are consistent with this diagnosis. Gram-negative bacilli, gram-negative cocci, and gram-negative spirillum bacteria are unlikely causes of this patient’s symptoms.

Clostridium difficile is a type of bacteria that is commonly found in hospitals. It produces a toxin that can damage the intestines and cause a condition called pseudomembranous colitis. This bacteria usually develops when the normal gut flora is disrupted by broad-spectrum antibiotics, with second and third generation cephalosporins being the leading cause. Other risk factors include the use of proton pump inhibitors. Symptoms of C. difficile infection include diarrhea, abdominal pain, and a raised white blood cell count. The severity of the infection can be determined using the Public Health England severity scale.

To diagnose C. difficile infection, a stool sample is tested for the presence of the C. difficile toxin. Treatment involves reviewing current antibiotic therapy and stopping antibiotics if possible. For a first episode of infection, oral vancomycin is the first-line therapy for 10 days, followed by oral fidaxomicin as second-line therapy and oral vancomycin with or without IV metronidazole as third-line therapy. Recurrent infections may require different treatment options, such as oral fidaxomicin within 12 weeks of symptom resolution or oral vancomycin or fidaxomicin after 12 weeks of symptom resolution. In life-threatening cases, oral vancomycin and IV metronidazole may be used, and surgery may be considered with specialist advice. Other therapies, such as bezlotoxumab and fecal microbiota transplant, may also be considered for preventing recurrences in certain cases.

Metaplasia refers to the conversion of one cell type to another. Although metaplasia itself does not directly cause cancer, prolonged exposure to factors that trigger metaplasia can eventually lead to malignant transformations in cells. In cases of H-Pylori induced ulcers, metaplastic changes in the duodenal cap are commonly observed. However, these changes usually disappear after the ulcer has healed and eradication therapy has been administered.

Metaplasia is a reversible process where differentiated cells transform into another cell type. This change may occur as an adaptive response to stress, where cells sensitive to adverse conditions are replaced by more resilient cell types. Metaplasia can be a normal physiological response, such as the transformation of cartilage into bone. The most common type of epithelial metaplasia involves the conversion of columnar cells to squamous cells, which can be caused by smoking or Schistosomiasis. In contrast, metaplasia from squamous to columnar cells occurs in Barrett’s esophagus. If the metaplastic stimulus is removed, the cells will revert to their original differentiation pattern. However, if the stimulus persists, dysplasia may develop. Although metaplasia is not directly carcinogenic, factors that predispose to metaplasia may induce malignant transformation. The pathogenesis of metaplasia involves the reprogramming of stem cells or undifferentiated mesenchymal cells present in connective tissue, which differentiate along a new pathway.

The mesentery is present in the stomach and the first part of the duodenum as they are intraperitoneal structures.

In the abdomen, organs are categorized as either intraperitoneal or retroperitoneal. The intraperitoneal organs include the stomach, spleen, liver, bulb of the duodenum, jejunum, ileum, transverse colon, and sigmoid colon. The retroperitoneal organs include the remaining part of the duodenum, the cecum and ascending colon, the descending colon, the pancreas, and the kidneys.

The peritoneum has different functions in the abdomen and can be classified accordingly. It is called a mesentery when it anchors organs to the posterior abdominal wall and a ligament when it connects two different organs. The lesser and greater curvatures of the stomach have folds known as the lesser and greater omenta.

The retroperitoneal structures are those that are located behind the peritoneum, which is the membrane that lines the abdominal cavity. These structures include the duodenum (2nd, 3rd, and 4th parts), ascending and descending colon, kidneys, ureters, aorta, and inferior vena cava. They are situated in the back of the abdominal cavity, close to the spine. In contrast, intraperitoneal structures are those that are located within the peritoneal cavity, such as the stomach, duodenum (1st part), jejunum, ileum, transverse colon, and sigmoid colon. It is important to note that the retroperitoneal structures are not well demonstrated in the diagram as the posterior aspect has been removed, but they are still significant in terms of their location and function.

Mesenteric infarcts can be caused by various factors such as prolonged atrial fibrillation, ventricular aneurysms, and post myocardial infarction.

Understanding Mesenteric Vessel Disease

Mesenteric vessel disease is a condition that affects the blood vessels supplying the intestines. It is primarily caused by arterial embolism, which can result in infarction of the colon. The most common type of mesenteric vessel disease is acute mesenteric embolus, which is characterized by sudden onset abdominal pain followed by profuse diarrhea. Other types include acute on chronic mesenteric ischemia, mesenteric vein thrombosis, and low flow mesenteric infarction.

Diagnosis of mesenteric vessel disease involves serological tests such as WCC, lactate, CRP, and amylase, as well as CT angiography scanning in the arterial phase with thin slices. Management of the condition depends on the severity of symptoms, with overt signs of peritonism requiring laparotomy and mesenteric vein thrombosis being treated with medical management using IV heparin. In cases where surgery is necessary, limited resection of necrotic bowel may be performed with the aim of relooking laparotomy at 24-48 hours.

The prognosis for mesenteric vessel disease is generally poor, with the best outlook being for acute ischaemia from an embolic event where surgery occurs within 12 hours. Survival rates may be as high as 50%, but this falls to 30% with treatment delay. It is important to seek medical attention promptly if symptoms of mesenteric vessel disease are present.

The incorrect HLA serotypes are HLA-A3, HLA-B27, and HLA-B51. HLA-A3 is associated with haemochromatosis, which can be asymptomatic in early stages and present with non-specific symptoms such as lethargy and arthralgia. HLA-B27 is associated with ankylosing spondylitis, reactive arthritis, and anterior uveitis. Ankylosing spondylitis presents with lower back pain and stiffness that worsens in the morning and improves with exercise. Reactive arthritis is characterized by arthritis following an infection, along with possible symptoms of urethritis and conjunctivitis. Anterior uveitis is inflammation of the iris and ciliary body and is a differential diagnosis for red eye. HLA-B51 is associated with Behçet’s disease, which involves oral and genital ulcers and anterior uveitis.

Understanding Coeliac Disease

Coeliac disease is an autoimmune disorder that affects approximately 1% of the UK population. It is caused by sensitivity to gluten, a protein found in wheat, barley, and rye. Repeated exposure to gluten leads to villous atrophy, which causes malabsorption. Coeliac disease is associated with various conditions, including dermatitis herpetiformis and autoimmune disorders such as type 1 diabetes mellitus and autoimmune hepatitis. It is strongly linked to HLA-DQ2 and HLA-DQ8.

To diagnose coeliac disease, NICE recommends screening patients who exhibit signs and symptoms such as chronic or intermittent diarrhea, failure to thrive or faltering growth in children, persistent or unexplained gastrointestinal symptoms, prolonged fatigue, recurrent abdominal pain, sudden or unexpected weight loss, unexplained anemia, autoimmune thyroid disease, dermatitis herpetiformis, irritable bowel syndrome, type 1 diabetes, and first-degree relatives with coeliac disease.

Complications of coeliac disease include anemia, hyposplenism, osteoporosis, osteomalacia, lactose intolerance, enteropathy-associated T-cell lymphoma of the small intestine, subfertility, and unfavorable pregnancy outcomes. In rare cases, it can lead to esophageal cancer and other malignancies.

The diagnosis of coeliac disease is confirmed through a duodenal biopsy, which shows complete atrophy of the villi with flat mucosa and marked crypt hyperplasia, intraepithelial lymphocytosis, and dense mixed inflammatory infiltrate in the lamina propria. Treatment involves a lifelong gluten-free diet.

The causative organism in pseudomembranous colitis following recent broad-spectrum antibiotic use is Clostridium difficile, a gram-positive bacillus. This woman’s clinical presentation is consistent with C. diff infection, as she has experienced multiple episodes of loose stool with abdominal pain and has risk factors such as residing in a care home and recent antibiotic use for chest infections. While gram-negative comma-shaped bacteria like Vibrio cholerae can cause cholera, it is not found in the UK and is therefore unlikely to be the cause here. Gram-negative rods like Escherichia coli or Campylobacter jejuni can cause diarrhoeal illnesses, but are more associated with bloody diarrhoea and food poisoning, which do not match this woman’s symptoms. Gram-positive rods like Bacillus cereus can cause vomiting or diarrhoeal illness from contaminated food, but antibiotics are not beneficial and vancomycin would not be needed. Given the woman’s risk factors and symptoms, C. diff is the most likely cause.

Clostridium difficile is a type of bacteria that is commonly found in hospitals. It produces a toxin that can damage the intestines and cause a condition called pseudomembranous colitis. This bacteria usually develops when the normal gut flora is disrupted by broad-spectrum antibiotics, with second and third generation cephalosporins being the leading cause. Other risk factors include the use of proton pump inhibitors. Symptoms of C. difficile infection include diarrhea, abdominal pain, and a raised white blood cell count. The severity of the infection can be determined using the Public Health England severity scale.

To diagnose C. difficile infection, a stool sample is tested for the presence of the C. difficile toxin. Treatment involves reviewing current antibiotic therapy and stopping antibiotics if possible. For a first episode of infection, oral vancomycin is the first-line therapy for 10 days, followed by oral fidaxomicin as second-line therapy and oral vancomycin with or without IV metronidazole as third-line therapy. Recurrent infections may require different treatment options, such as oral fidaxomicin within 12 weeks of symptom resolution or oral vancomycin or fidaxomicin after 12 weeks of symptom resolution. In life-threatening cases, oral vancomycin and IV metronidazole may be used, and surgery may be considered with specialist advice. Other therapies, such as bezlotoxumab and fecal microbiota transplant, may also be considered for preventing recurrences in certain cases.

Polyposis syndromes are a group of genetic disorders that cause the development of multiple polyps in the colon and other parts of the gastrointestinal tract. These polyps can increase the risk of developing cancer, and therefore, early detection and management are crucial. There are several types of polyposis syndromes, each with its own genetic defect, features, and associated disorders.

Familial adenomatous polyposis (FAP) is caused by a mutation in the APC gene and is characterized by the development of over 100 colonic adenomas, with a 100% risk of cancer. Screening and management involve regular colonoscopies and resectional surgery if polyps are found. FAP is also associated with gastric and duodenal polyps and abdominal desmoid tumors.

MYH-associated polyposis is caused by a biallelic mutation of the MYH gene and is associated with multiple colonic polyps and an increased risk of right-sided cancers. Attenuated phenotype can be managed with regular colonoscopies, while resection and ileoanal pouch reconstruction are recommended for those with multiple polyps.

Peutz-Jeghers syndrome is caused by a mutation in the STK11 gene and is characterized by multiple benign intestinal hamartomas, episodic obstruction, and an increased risk of GI cancers. Screening involves annual examinations and pan-intestinal endoscopy every 2-3 years.

Cowden disease is caused by a mutation in the PTEN gene and is characterized by macrocephaly, multiple intestinal hamartomas, and an increased risk of cancer at any site. Targeted individualized screening is recommended, with extra surveillance for breast, thyroid, and uterine cancers.

HNPCC (Lynch syndrome) is caused by germline mutations of DNA mismatch repair genes and is associated with an increased risk of colorectal, endometrial, and gastric cancers. Colonoscopies every 1-2 years from age 25 and consideration of prophylactic surgery are recommended, along with extra colonic surveillance.

Understanding Coeliac Disease

Coeliac disease is an autoimmune disorder that affects approximately 1% of the UK population. It is caused by sensitivity to gluten, a protein found in wheat, barley, and rye. Repeated exposure to gluten leads to villous atrophy, which causes malabsorption. Coeliac disease is associated with various conditions, including dermatitis herpetiformis and autoimmune disorders such as type 1 diabetes mellitus and autoimmune hepatitis. It is strongly linked to HLA-DQ2 and HLA-DQ8.

To diagnose coeliac disease, NICE recommends screening patients who exhibit signs and symptoms such as chronic or intermittent diarrhea, failure to thrive or faltering growth in children, persistent or unexplained gastrointestinal symptoms, prolonged fatigue, recurrent abdominal pain, sudden or unexpected weight loss, unexplained anemia, autoimmune thyroid disease, dermatitis herpetiformis, irritable bowel syndrome, type 1 diabetes, and first-degree relatives with coeliac disease.

Complications of coeliac disease include anemia, hyposplenism, osteoporosis, osteomalacia, lactose intolerance, enteropathy-associated T-cell lymphoma of the small intestine, subfertility, and unfavorable pregnancy outcomes. In rare cases, it can lead to esophageal cancer and other malignancies.

The diagnosis of coeliac disease is confirmed through a duodenal biopsy, which shows complete atrophy of the villi with flat mucosa and marked crypt hyperplasia, intraepithelial lymphocytosis, and dense mixed inflammatory infiltrate in the lamina propria. Treatment involves a lifelong gluten-free diet.

The hormone that increases gallbladder contraction is Cholecystokinin (CCK). It is secreted by I cells in the upper small intestine, particularly in response to a high-fat meal. Although it has many functions, its role in increasing gallbladder contraction may exacerbate biliary colic caused by gallstones in the patient described.

Gastrin, insulin, and secretin are also hormones that can be released in response to food intake, but they do not have any known effect on gallbladder contraction. Therefore, CCK is the most appropriate answer.

Overview of Gastrointestinal Hormones

Gastrointestinal hormones play a crucial role in the digestion and absorption of food. These hormones are secreted by various cells in the stomach and small intestine in response to different stimuli such as the presence of food, pH changes, and neural signals.

One of the major hormones involved in food digestion is gastrin, which is secreted by G cells in the antrum of the stomach. Gastrin increases acid secretion by gastric parietal cells, stimulates the secretion of pepsinogen and intrinsic factor, and increases gastric motility. Another hormone, cholecystokinin (CCK), is secreted by I cells in the upper small intestine in response to partially digested proteins and triglycerides. CCK increases the secretion of enzyme-rich fluid from the pancreas, contraction of the gallbladder, and relaxation of the sphincter of Oddi. It also decreases gastric emptying and induces satiety.

Secretin is another hormone secreted by S cells in the upper small intestine in response to acidic chyme and fatty acids. Secretin increases the secretion of bicarbonate-rich fluid from the pancreas and hepatic duct cells, decreases gastric acid secretion, and has a trophic effect on pancreatic acinar cells. Vasoactive intestinal peptide (VIP) is a neural hormone that stimulates secretion by the pancreas and intestines and inhibits acid secretion.

Finally, somatostatin is secreted by D cells in the pancreas and stomach in response to fat, bile salts, and glucose in the intestinal lumen. Somatostatin decreases acid and pepsin secretion, decreases gastrin secretion, decreases pancreatic enzyme secretion, and decreases insulin and glucagon secretion. It also inhibits the trophic effects of gastrin and stimulates gastric mucous production.

In summary, gastrointestinal hormones play a crucial role in regulating the digestive process and maintaining homeostasis in the gastrointestinal tract.

Understanding Gastric Secretions for Surgical Procedures

A basic understanding of gastric secretions is crucial for surgeons, especially when dealing with patients who have undergone acid-lowering procedures or are prescribed anti-secretory drugs. Gastric acid, produced by the parietal cells in the stomach, has a pH of around 2 and is maintained by the H+/K+ ATPase pump. Sodium and chloride ions are actively secreted from the parietal cell into the canaliculus, creating a negative potential across the membrane. Carbonic anhydrase forms carbonic acid, which dissociates, and the hydrogen ions formed by dissociation leave the cell via the H+/K+ antiporter pump. This leaves hydrogen and chloride ions in the canaliculus, which mix and are secreted into the lumen of the oxyntic gland.

There are three phases of gastric secretion: the cephalic phase, gastric phase, and intestinal phase. The cephalic phase is stimulated by the smell or taste of food and causes 30% of acid production. The gastric phase, which is caused by stomach distension, low H+, or peptides, causes 60% of acid production. The intestinal phase, which is caused by high acidity, distension, or hypertonic solutions in the duodenum, inhibits gastric acid secretion via enterogastrones and neural reflexes.

The regulation of gastric acid production involves various factors that increase or decrease production. Factors that increase production include vagal nerve stimulation, gastrin release, and histamine release. Factors that decrease production include somatostatin, cholecystokinin, and secretin. Understanding these factors and their associated pharmacology is essential for surgeons.

In summary, a working knowledge of gastric secretions is crucial for surgical procedures, especially when dealing with patients who have undergone acid-lowering procedures or are prescribed anti-secretory drugs. Understanding the phases of gastric secretion and the regulation of gastric acid production is essential for successful surgical outcomes.

Ischaemic colitis most frequently affects the splenic flexure.

Understanding Ischaemic Colitis

Ischaemic colitis is a condition that occurs when there is a temporary reduction in blood flow to the large bowel. This can cause inflammation, ulcers, and bleeding. The condition is more likely to occur in areas of the bowel that are located at the borders of the territory supplied by the superior and inferior mesenteric arteries, such as the splenic flexure.

When investigating ischaemic colitis, doctors may look for a sign called thumbprinting on an abdominal x-ray. This occurs due to mucosal edema and hemorrhage. It is important to diagnose and treat ischaemic colitis promptly to prevent complications and ensure a full recovery.

Understanding the Anatomy of the Femoral Triangle

The femoral triangle is an important anatomical region located in the upper thigh. It is bounded by the inguinal ligament superiorly, the sartorius muscle laterally, and the adductor longus muscle medially. The floor of the femoral triangle is made up of the iliacus, psoas major, adductor longus, and pectineus muscles, while the roof is formed by the fascia lata and superficial fascia. The superficial inguinal lymph nodes and the long saphenous vein are also found in this region.

The femoral triangle contains several important structures, including the femoral vein, femoral artery, femoral nerve, deep and superficial inguinal lymph nodes, lateral cutaneous nerve, great saphenous vein, and femoral branch of the genitofemoral nerve. The femoral artery can be palpated at the mid inguinal point, making it an important landmark for medical professionals.

Understanding the anatomy of the femoral triangle is important for medical professionals, as it is a common site for procedures such as venipuncture, arterial puncture, and nerve blocks. It is also important for identifying and treating conditions that affect the structures within this region, such as femoral hernias and lymphadenopathy.

Chronic pancreatitis can cause diabetes as it destroys the islet of Langerhans cells in the pancreas. This patient has a history of recurrent admissions due to alcohol-related falls, indicating excessive alcohol intake, which is the most common risk factor for chronic pancreatitis. A high sugar diet alone should not consistently elevated blood sugar levels if normal insulin control mechanisms are functioning properly. Gastrointestinal bleeding and the stress response to injury would not immediately raise blood sugar levels. In this case, the patient’s alcohol intake suggests chronic pancreatitis as the cause of elevated blood sugar levels rather than type 2 diabetes mellitus.

Understanding Chronic Pancreatitis

Chronic pancreatitis is a condition characterized by inflammation that can affect both the exocrine and endocrine functions of the pancreas. While alcohol excess is the leading cause of this condition, up to 20% of cases are unexplained. Other causes include genetic factors such as cystic fibrosis and haemochromatosis, as well as ductal obstruction due to tumors, stones, and structural abnormalities.

Symptoms of chronic pancreatitis include pain that worsens 15 to 30 minutes after a meal, steatorrhoea, and diabetes mellitus. Abdominal x-rays and CT scans are used to detect pancreatic calcification, which is present in around 30% of cases. Functional tests such as faecal elastase may also be used to assess exocrine function if imaging is inconclusive.

Management of chronic pancreatitis involves pancreatic enzyme supplements, analgesia, and antioxidants. While there is limited evidence to support the use of antioxidants, one study suggests that they may be beneficial in early stages of the disease. Overall, understanding the causes and symptoms of chronic pancreatitis is crucial for effective management and treatment.

The renal artery provides branches that supply the proximal ureter, while other feeding vessels are described in the following.

Anatomy of the Ureter

The ureter is a muscular tube that measures 25-35 cm in length and is lined by transitional epithelium. It is surrounded by a thick muscular coat that becomes three muscular layers as it crosses the bony pelvis. This retroperitoneal structure overlies the transverse processes L2-L5 and lies anterior to the bifurcation of iliac vessels. The blood supply to the ureter is segmental and includes the renal artery, aortic branches, gonadal branches, common iliac, and internal iliac. It is important to note that the ureter lies beneath the uterine artery.

In summary, the ureter is a vital structure in the urinary system that plays a crucial role in transporting urine from the kidneys to the bladder. Its unique anatomy and blood supply make it a complex structure that requires careful consideration in any surgical or medical intervention.

It is probable that he has a duodenal ulcer located at the back. Such ulcers can penetrate the gastroduodenal artery and result in significant bleeding. While gastric ulcers can also invade vessels, they are not typically associated with major bleeding of this type.

The Gastroduodenal Artery: Supply and Path

The gastroduodenal artery is responsible for supplying blood to the pylorus, proximal part of the duodenum, and indirectly to the pancreatic head through the anterior and posterior superior pancreaticoduodenal arteries. It commonly arises from the common hepatic artery of the coeliac trunk and terminates by bifurcating into the right gastroepiploic artery and the superior pancreaticoduodenal artery.

To better understand the relationship of the gastroduodenal artery to the first part of the duodenum, the stomach is reflected superiorly in an image sourced from Wikipedia. This artery plays a crucial role in providing oxygenated blood to the digestive system, ensuring proper functioning and health.

Large bowel obstruction is the most likely diagnosis based on the pattern of symptoms, which include abdominal distension, absence of passing flatus or stool, and late onset or no vomiting.

Large bowel obstruction occurs when there is a blockage in the passage of food, fluids, and gas through the large intestines. The most common cause of this condition is a tumor, accounting for 60% of cases. Colonic malignancy is often the initial presenting complaint in approximately 30% of cases, especially in more distal colonic and rectal tumors due to their smaller lumen diameter. Other causes include volvulus and diverticular disease.

Clinical features of large bowel obstruction include abdominal pain, distention, and absence of passing flatus or stool. Nausea and vomiting may suggest a more proximal lesion, while peritonism may be present if there is associated bowel perforation. It is important to consider the underlying causes, such as recent symptoms suggestive of colorectal cancer.

Abdominal x-ray is still commonly used as a first-line investigation, with a diameter greater than the normal limits of 10-12 cm for the caecum, 8 cm for the ascending colon, and 6.5 cm for recto-sigmoid being diagnostic of obstruction. CT scan is highly sensitive and specific for identifying obstruction and its underlying cause.

Initial management of large bowel obstruction includes NBM, IV fluids, and nasogastric tube with free drainage. Conservative management for up to 72 hours can be trialed if the cause of obstruction does not require surgery, after which further management may be required if there is no resolution. Around 75% of cases will eventually require surgery. IV antibiotics are given if perforation is suspected or surgery is planned. Emergency surgery is necessary if there is any overt peritonitis or evidence of bowel perforation, involving irrigation of the abdominal cavity, resection of perforated segment and ischaemic bowel, and addressing the underlying cause of the obstruction.

ASCA, also known as anti-Saccharomyces cerevisiae antibodies, can be abbreviated as 6.

Inflammatory bowel disease (IBD) is a condition that includes two main types: Crohn’s disease and ulcerative colitis. Although they share many similarities in terms of symptoms, diagnosis, and treatment, there are some key differences between the two. Crohn’s disease is characterized by non-bloody diarrhea, weight loss, upper gastrointestinal symptoms, mouth ulcers, perianal disease, and a palpable abdominal mass in the right iliac fossa. On the other hand, ulcerative colitis is characterized by bloody diarrhea, abdominal pain in the left lower quadrant, tenesmus, gallstones, and primary sclerosing cholangitis. Complications of Crohn’s disease include obstruction, fistula, and colorectal cancer, while ulcerative colitis has a higher risk of colorectal cancer than Crohn’s disease. Pathologically, Crohn’s disease lesions can be seen anywhere from the mouth to anus, while ulcerative colitis inflammation always starts at the rectum and never spreads beyond the ileocaecal valve. Endoscopy and radiology can help diagnose and differentiate between the two types of IBD.